Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Lantheus Holdings share price today

Lantheus Holdings, Inc. · LNTH · Healthcare · Drug Manufacturers - Specialty & Generic · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

Lantheus Holdings share price: $101.14 at the close on 4 November 2026, +98.0% in a year.

Getting betterBusiness trend from the last 12 quarters
$101.14Price +98.0% in a year
24.4×P/E higher than 54% of the last 4.3 years
$388 MRevenue (Jun 2026) +2.7% on a year ago
$75.0 MProfit (Jun 2026) −4.7% on a year ago
25.8%Operating margin +2.5 points on a year ago
21%ROE FY25
17.2%ROIC against a 4.2% cost of capital: +13.0 points

Lantheus Holdings, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.

The main question: the share price moved +98.0% in a year while yearly earnings per share moved −21.8%. The difference came from the market paying a higher multiple.

The price has been rising for 18 weeks, and the P/E is higher than 54% of its own last 4.3 years. Over the last four quarters, results have been improving, with profit −4.7% on a year earlier, and 142% of the last 3 years' profit came in as cash. What will decide it: whether earnings grow into a price that has already moved.

What is the Lantheus Holdings share price today?

Lantheus Holdings, Inc.'s share price was $101.14 at the close on 4 November 2026. It has been rising for 18 weeks. That is 10.0% above its average price over the last 200 trading days. In the last 52 weeks it traded between $51 and $110, and at that close it sat 85% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Lantheus Holdings, Inc. is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row.

1Y

Nov 2026: $101.14, 10.0% above its 200-day average. The price has been rising for 18 weeks.

  • Price $101.14
  • 50-day avg $100.27
  • 200-day avg $91.91
Nov 2026: $101.14, 10.0% above its 200-day average. The price has been rising for 18 weeks.
WeekPrice50-day avg200-day avg
31 Oct 2025$57.69$54.20$77.42
7 Nov 2025$51.07$54.09$76.45
14 Nov 2025$53.01$53.90$75.41
21 Nov 2025$55.82$53.88$74.47
28 Nov 2025$58.87$54.42$73.94
5 Dec 2025$63.30$55.33$73.42
12 Dec 2025$66.62$56.47$72.88
19 Dec 2025$65.92$57.74$72.08
26 Dec 2025$66.71$58.70$71.31
2 Jan 2026$67.27$59.54$70.62
9 Jan 2026$67.56$60.71$69.84
16 Jan 2026$64.25$61.61$69.05
23 Jan 2026$67.51$62.69$68.48
30 Jan 2026$66.92$64.08$67.68
6 Feb 2026$64.89$65.20$66.80
13 Feb 2026$69.38$66.06$65.92
20 Feb 2026$73.87$66.95$65.24
27 Feb 2026$74.91$68.05$64.97
6 Mar 2026$72.56$69.10$64.89
13 Mar 2026$79.49$70.53$65.04
20 Mar 2026$76.43$71.57$65.11
27 Mar 2026$74.47$72.41$64.97
2 Apr 2026$76.10$73.18$64.89
10 Apr 2026$80.59$74.37$64.88
17 Apr 2026$83.82$76.05$64.94
24 Apr 2026$84.33$77.77$64.99
1 May 2026$85.50$79.04$65.07
8 May 2026$93.06$80.48$65.48
15 May 2026$93.91$82.34$66.06
22 May 2026$103.00$83.95$66.77
29 May 2026$99.30$85.54$67.65
5 Jun 2026$100.98$87.89$68.77
12 Jun 2026$104.52$90.56$69.89
18 Jun 2026$103.86$92.69$70.86
26 Jun 2026$109.80$95.21$72.18
2 Jul 2026$109.89$97.33$73.32
10 Jul 2026$105.64$99.47$74.67
17 Jul 2026$107.59$101.46$76.00
24 Jul 2026$104.82$102.76$77.32
31 Jul 2026$99.64$103.53$78.54
7 Aug 2026$100.95$103.79$79.67
14 Aug 2026$100.95$104.02$80.76
21 Aug 2026$99.97$103.98$81.86
28 Aug 2026$100.77$103.62$83.02
4 Sep 2026$100.97$103.11$84.22
11 Sep 2026$100.25$102.36$85.15
18 Sep 2026$100.55$101.84$86.20
25 Sep 2026$99.74$101.38$87.17
2 Oct 2026$99.96$100.78$88.07
9 Oct 2026$100.15$100.47$88.93
16 Oct 2026$99.70$100.37$89.76
23 Oct 2026$99.80$100.30$90.55
30 Oct 2026$100.46$100.26$91.38
4 Nov 2026$101.14$100.27$91.91
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: $101.14, 10.0% above its 200-day average. The price has been rising for 18 weeks.

  • Price $101.14
  • 50-day avg $100.27
  • 200-day avg $91.91
Nov 2026: $101.14, 10.0% above its 200-day average. The price has been rising for 18 weeks.
WeekPrice50-day avg200-day avg
3 Nov 2023$64.32$66.78$76.29
10 Nov 2023$63.47$66.43$76.52
17 Nov 2023$68.20$66.53$76.76
24 Nov 2023$68.82$66.85$76.93
1 Dec 2023$73.79$67.68$77.24
8 Dec 2023$73.71$68.41$77.53
15 Dec 2023$76.04$68.91$77.59
22 Dec 2023$59.59$67.87$77.22
29 Dec 2023$62.00$67.20$77.02
5 Jan 2024$64.49$66.79$76.70
12 Jan 2024$56.24$66.30$76.19
19 Jan 2024$53.08$65.54$75.66
26 Jan 2024$52.88$64.44$74.87
2 Feb 2024$54.00$62.92$74.00
9 Feb 2024$56.14$61.52$73.11
16 Feb 2024$57.46$59.90$72.42
23 Feb 2024$66.27$59.06$71.81
1 Mar 2024$64.64$58.46$71.00
8 Mar 2024$62.52$58.84$70.15
15 Mar 2024$58.17$58.63$69.31
22 Mar 2024$59.02$58.14$68.57
28 Mar 2024$62.24$58.47$68.04
5 Apr 2024$60.83$59.12$67.32
12 Apr 2024$60.79$59.87$66.59
19 Apr 2024$63.81$60.65$66.05
26 Apr 2024$65.56$61.53$65.59
3 May 2024$75.53$62.75$65.18
10 May 2024$76.02$63.64$64.94
17 May 2024$79.67$65.20$64.80
24 May 2024$78.22$67.13$65.01
31 May 2024$81.83$68.92$65.24
7 Jun 2024$79.90$71.17$65.62
14 Jun 2024$79.26$73.17$65.96
21 Jun 2024$79.10$74.84$66.24
28 Jun 2024$80.29$76.74$66.60
5 Jul 2024$78.89$78.01$66.89
12 Jul 2024$123.42$81.61$67.88
19 Jul 2024$116.79$86.07$69.17
26 Jul 2024$112.71$89.80$70.24
2 Aug 2024$97.59$92.17$71.15
9 Aug 2024$97.33$93.97$71.83
16 Aug 2024$94.91$95.36$72.58
23 Aug 2024$107.16$97.46$73.51
30 Aug 2024$106.47$100.11$74.61
6 Sep 2024$101.98$102.13$75.34
13 Sep 2024$105.55$104.36$76.17
20 Sep 2024$110.05$105.85$77.06
27 Sep 2024$107.36$104.66$77.98
4 Oct 2024$107.78$103.89$78.85
11 Oct 2024$112.19$104.03$80.08
18 Oct 2024$116.69$105.61$81.36
25 Oct 2024$110.30$107.09$82.55
1 Nov 2024$107.98$108.15$83.89
8 Nov 2024$87.50$107.33$85.06
15 Nov 2024$76.83$104.95$85.77
22 Nov 2024$90.52$103.13$86.50
29 Nov 2024$89.27$101.74$87.18
6 Dec 2024$89.02$99.73$87.94
13 Dec 2024$93.02$98.23$88.57
20 Dec 2024$89.28$96.61$89.27
27 Dec 2024$92.07$95.01$89.88
3 Jan 2025$91.21$93.04$90.51
10 Jan 2025$95.88$91.84$91.23
17 Jan 2025$91.47$90.06$92.05
24 Jan 2025$97.50$90.11$92.77
31 Jan 2025$92.51$91.32$93.59
7 Feb 2025$88.71$91.95$94.29
14 Feb 2025$79.94$91.22$94.72
21 Feb 2025$78.23$90.58$94.90
28 Feb 2025$93.82$90.13$95.19
7 Mar 2025$106.34$90.96$95.71
14 Mar 2025$101.10$92.15$96.28
21 Mar 2025$97.71$93.04$96.78
28 Mar 2025$96.16$93.44$97.21
4 Apr 2025$90.92$93.66$97.60
11 Apr 2025$102.00$94.01$98.03
17 Apr 2025$101.32$94.86$98.47
25 Apr 2025$101.77$96.38$99.03
2 May 2025$108.74$98.74$98.69
9 May 2025$81.74$99.41$98.04
16 May 2025$81.24$97.63$97.23
23 May 2025$73.86$94.78$96.63
30 May 2025$75.56$92.62$96.20
6 Jun 2025$81.55$90.66$95.78
13 Jun 2025$77.83$88.98$95.21
20 Jun 2025$79.19$87.72$94.63
27 Jun 2025$81.49$85.70$94.06
3 Jul 2025$80.42$84.09$93.61
11 Jul 2025$81.31$82.03$92.96
18 Jul 2025$70.18$79.04$92.16
25 Jul 2025$72.93$78.24$91.29
1 Aug 2025$70.57$77.51$90.36
8 Aug 2025$57.20$76.19$89.06
15 Aug 2025$54.18$73.93$87.65
22 Aug 2025$58.21$71.50$86.33
29 Aug 2025$54.90$69.22$85.24
5 Sep 2025$54.75$67.17$84.69
12 Sep 2025$52.94$64.49$84.00
19 Sep 2025$50.41$61.44$83.03
26 Sep 2025$50.61$58.71$82.09
3 Oct 2025$53.83$56.75$81.09
10 Oct 2025$53.54$54.82$80.12
17 Oct 2025$55.60$53.95$79.23
24 Oct 2025$56.06$54.12$78.35
31 Oct 2025$57.69$54.20$77.42
7 Nov 2025$51.07$54.09$76.45
14 Nov 2025$53.01$53.90$75.41
21 Nov 2025$55.82$53.88$74.47
28 Nov 2025$58.87$54.42$73.94
5 Dec 2025$63.30$55.33$73.42
12 Dec 2025$66.62$56.47$72.88
19 Dec 2025$65.92$57.74$72.08
26 Dec 2025$66.71$58.70$71.31
2 Jan 2026$67.27$59.54$70.62
9 Jan 2026$67.56$60.71$69.84
16 Jan 2026$64.25$61.61$69.05
23 Jan 2026$67.51$62.69$68.48
30 Jan 2026$66.92$64.08$67.68
6 Feb 2026$64.89$65.20$66.80
13 Feb 2026$69.38$66.06$65.92
20 Feb 2026$73.87$66.95$65.24
27 Feb 2026$74.91$68.05$64.97
6 Mar 2026$72.56$69.10$64.89
13 Mar 2026$79.49$70.53$65.04
20 Mar 2026$76.43$71.57$65.11
27 Mar 2026$74.47$72.41$64.97
2 Apr 2026$76.10$73.18$64.89
10 Apr 2026$80.59$74.37$64.88
17 Apr 2026$83.82$76.05$64.94
24 Apr 2026$84.33$77.77$64.99
1 May 2026$85.50$79.04$65.07
8 May 2026$93.06$80.48$65.48
15 May 2026$93.91$82.34$66.06
22 May 2026$103.00$83.95$66.77
29 May 2026$99.30$85.54$67.65
5 Jun 2026$100.98$87.89$68.77
12 Jun 2026$104.52$90.56$69.89
18 Jun 2026$103.86$92.69$70.86
26 Jun 2026$109.80$95.21$72.18
2 Jul 2026$109.89$97.33$73.32
10 Jul 2026$105.64$99.47$74.67
17 Jul 2026$107.59$101.46$76.00
24 Jul 2026$104.82$102.76$77.32
31 Jul 2026$99.64$103.53$78.54
7 Aug 2026$100.95$103.79$79.67
14 Aug 2026$100.95$104.02$80.76
21 Aug 2026$99.97$103.98$81.86
28 Aug 2026$100.77$103.62$83.02
4 Sep 2026$100.97$103.11$84.22
11 Sep 2026$100.25$102.36$85.15
18 Sep 2026$100.55$101.84$86.20
25 Sep 2026$99.74$101.38$87.17
2 Oct 2026$99.96$100.78$88.07
9 Oct 2026$100.15$100.47$88.93
16 Oct 2026$99.70$100.37$89.76
23 Oct 2026$99.80$100.30$90.55
30 Oct 2026$100.46$100.26$91.38
4 Nov 2026$101.14$100.27$91.91
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 3-year window.

5Y

Nov 2026: $101.14, 10.0% above its 200-day average. The price has been rising for 18 weeks.

  • Price $101.14
  • 50-day avg $100.27
  • 200-day avg $91.91
Nov 2026: $101.14, 10.0% above its 200-day average. The price has been rising for 18 weeks.
WeekPrice50-day avg200-day avg
29 Oct 2021$23.39$24.96$22.93
12 Nov 2021$30.44$25.40$23.53
26 Nov 2021$27.89$25.96$23.99
10 Dec 2021$27.20$26.11$24.38
23 Dec 2021$29.41$26.69$24.76
7 Jan 2022$26.89$27.86$25.21
21 Jan 2022$25.23$27.90$25.46
4 Feb 2022$26.56$27.11$25.66
18 Feb 2022$28.85$27.36$25.94
4 Mar 2022$52.30$30.40$26.98
18 Mar 2022$54.97$35.07$28.49
1 Apr 2022$58.36$40.65$29.98
14 Apr 2022$60.28$46.68$31.44
29 Apr 2022$66.41$53.20$33.09
13 May 2022$64.00$57.60$34.91
27 May 2022$70.34$60.20$36.86
10 Jun 2022$63.85$62.97$38.87
24 Jun 2022$62.82$63.62$40.46
8 Jul 2022$67.79$64.42$42.21
22 Jul 2022$68.66$65.77$44.37
5 Aug 2022$78.57$68.00$46.91
19 Aug 2022$82.47$70.54$49.87
2 Sep 2022$78.48$74.20$52.45
16 Sep 2022$79.51$77.72$54.94
30 Sep 2022$70.33$78.08$57.13
14 Oct 2022$68.84$77.57$59.25
28 Oct 2022$75.45$75.79$61.51
11 Nov 2022$56.47$72.02$63.34
25 Nov 2022$58.45$67.36$64.74
9 Dec 2022$53.31$64.58$66.13
23 Dec 2022$50.63$60.93$66.25
6 Jan 2023$48.48$57.41$66.09
20 Jan 2023$53.42$54.41$65.97
3 Feb 2023$60.80$54.37$65.85
17 Feb 2023$59.72$54.35$65.74
3 Mar 2023$72.94$57.19$66.07
17 Mar 2023$77.84$61.80$66.49
31 Mar 2023$82.56$67.70$67.12
14 Apr 2023$88.67$72.97$68.14
28 Apr 2023$85.45$78.84$69.32
12 May 2023$99.65$83.97$70.43
26 May 2023$91.05$88.64$71.41
9 Jun 2023$85.97$90.02$71.64
23 Jun 2023$92.52$91.05$72.04
7 Jul 2023$82.40$89.94$72.05
21 Jul 2023$87.54$89.49$72.84
4 Aug 2023$75.69$86.41$73.43
18 Aug 2023$66.28$82.10$73.19
1 Sep 2023$67.30$77.76$73.51
15 Sep 2023$64.81$74.28$73.85
29 Sep 2023$69.48$70.06$74.22
13 Oct 2023$67.47$67.19$75.08
27 Oct 2023$66.83$67.05$76.04
10 Nov 2023$63.47$66.43$76.52
24 Nov 2023$68.82$66.85$76.93
8 Dec 2023$73.71$68.41$77.53
22 Dec 2023$59.59$67.87$77.22
5 Jan 2024$64.49$66.79$76.70
19 Jan 2024$53.08$65.54$75.66
2 Feb 2024$54.00$62.92$74.00
16 Feb 2024$57.46$59.90$72.42
1 Mar 2024$64.64$58.46$71.00
15 Mar 2024$58.17$58.63$69.31
28 Mar 2024$62.24$58.47$68.04
12 Apr 2024$60.79$59.87$66.59
26 Apr 2024$65.56$61.53$65.59
10 May 2024$76.02$63.64$64.94
24 May 2024$78.22$67.13$65.01
7 Jun 2024$79.90$71.17$65.62
21 Jun 2024$79.10$74.84$66.24
5 Jul 2024$78.89$78.01$66.89
19 Jul 2024$116.79$86.07$69.17
2 Aug 2024$97.59$92.17$71.15
16 Aug 2024$94.91$95.36$72.58
30 Aug 2024$106.47$100.11$74.61
13 Sep 2024$105.55$104.36$76.17
27 Sep 2024$107.36$104.66$77.98
11 Oct 2024$112.19$104.03$80.08
25 Oct 2024$110.30$107.09$82.55
8 Nov 2024$87.50$107.33$85.06
22 Nov 2024$90.52$103.13$86.50
6 Dec 2024$89.02$99.73$87.94
20 Dec 2024$89.28$96.61$89.27
3 Jan 2025$91.21$93.04$90.51
17 Jan 2025$91.47$90.06$92.05
31 Jan 2025$92.51$91.32$93.59
14 Feb 2025$79.94$91.22$94.72
28 Feb 2025$93.82$90.13$95.19
14 Mar 2025$101.10$92.15$96.28
28 Mar 2025$96.16$93.44$97.21
11 Apr 2025$102.00$94.01$98.03
25 Apr 2025$101.77$96.38$99.03
9 May 2025$81.74$99.41$98.04
23 May 2025$73.86$94.78$96.63
6 Jun 2025$81.55$90.66$95.78
20 Jun 2025$79.19$87.72$94.63
3 Jul 2025$80.42$84.09$93.61
18 Jul 2025$70.18$79.04$92.16
1 Aug 2025$70.57$77.51$90.36
15 Aug 2025$54.18$73.93$87.65
29 Aug 2025$54.90$69.22$85.24
12 Sep 2025$52.94$64.49$84.00
26 Sep 2025$50.61$58.71$82.09
10 Oct 2025$53.54$54.82$80.12
24 Oct 2025$56.06$54.12$78.35
7 Nov 2025$51.07$54.09$76.45
21 Nov 2025$55.82$53.88$74.47
5 Dec 2025$63.30$55.33$73.42
19 Dec 2025$65.92$57.74$72.08
2 Jan 2026$67.27$59.54$70.62
16 Jan 2026$64.25$61.61$69.05
30 Jan 2026$66.92$64.08$67.68
13 Feb 2026$69.38$66.06$65.92
27 Feb 2026$74.91$68.05$64.97
13 Mar 2026$79.49$70.53$65.04
27 Mar 2026$74.47$72.41$64.97
10 Apr 2026$80.59$74.37$64.88
24 Apr 2026$84.33$77.77$64.99
8 May 2026$93.06$80.48$65.48
22 May 2026$103.00$83.95$66.77
5 Jun 2026$100.98$87.89$68.77
18 Jun 2026$103.86$92.69$70.86
2 Jul 2026$109.89$97.33$73.32
17 Jul 2026$107.59$101.46$76.00
31 Jul 2026$99.64$103.53$78.54
14 Aug 2026$100.95$104.02$80.76
28 Aug 2026$100.77$103.62$83.02
11 Sep 2026$100.25$102.36$85.15
25 Sep 2026$99.74$101.38$87.17
9 Oct 2026$100.15$100.47$88.93
23 Oct 2026$99.80$100.30$90.55
4 Nov 2026$101.14$100.27$91.91
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 5-year window.

10Y

Nov 2026: $101.14, 10.0% above its 200-day average. The price has been rising for 18 weeks.

  • Price $101.14
  • 50-day avg $100.27
  • 200-day avg $91.91
Nov 2026: $101.14, 10.0% above its 200-day average. The price has been rising for 18 weeks.
WeekPrice50-day avg200-day avg
28 Oct 2016$8.15$8.47–
18 Nov 2016$9.25$8.66–
9 Dec 2016$9.45$8.96–
30 Dec 2016$8.60$9.13–
20 Jan 2017$9.15$9.10–
10 Feb 2017$9.35$8.89–
3 Mar 2017$13.40$9.49–
24 Mar 2017$11.90$10.69–
13 Apr 2017$10.85$11.59–
5 May 2017$13.60$12.50$9.39
26 May 2017$17.05$13.46$10.27
16 Jun 2017$15.10$14.57$10.87
7 Jul 2017$18.00$15.97$11.43
28 Jul 2017$19.55$17.12$12.20
18 Aug 2017$15.85$17.35$12.86
8 Sep 2017$16.50$17.63$13.37
29 Sep 2017$17.80$17.41$13.97
20 Oct 2017$18.25$17.32$14.67
10 Nov 2017$22.25$18.44$15.55
1 Dec 2017$21.85$19.93$16.49
22 Dec 2017$20.55$20.69$17.08
12 Jan 2018$23.48$21.59$17.70
2 Feb 2018$21.90$21.88$18.48
23 Feb 2018$19.80$21.44$18.98
16 Mar 2018$16.20$20.10$18.96
6 Apr 2018$15.35$18.20$18.94
27 Apr 2018$18.00$16.73$18.91
18 May 2018$14.25$16.10$18.70
8 Jun 2018$14.10$15.61$18.50
29 Jun 2018$14.55$15.22$18.33
20 Jul 2018$13.70$14.51$18.12
10 Aug 2018$13.10$14.32$17.79
31 Aug 2018$16.10$14.25$17.30
21 Sep 2018$15.65$14.52$16.86
12 Oct 2018$13.27$14.72$16.40
2 Nov 2018$15.07$14.67$15.77
23 Nov 2018$16.15$14.75$15.29
14 Dec 2018$17.29$15.33$15.18
4 Jan 2019$15.70$15.72$15.13
25 Jan 2019$16.94$16.33$15.18
15 Feb 2019$18.54$16.55$15.20
8 Mar 2019$23.45$18.35$15.74
29 Mar 2019$24.48$20.87$16.48
18 Apr 2019$24.15$23.15$17.20
10 May 2019$25.50$24.50$17.98
31 May 2019$23.99$24.77$18.76
21 Jun 2019$27.85$25.22$19.63
12 Jul 2019$27.76$26.13$20.48
2 Aug 2019$22.49$26.30$21.32
23 Aug 2019$21.93$25.62$22.00
13 Sep 2019$24.62$24.12$22.46
4 Oct 2019$19.74$23.15$22.99
25 Oct 2019$19.46$22.00$23.25
15 Nov 2019$21.54$21.57$23.57
6 Dec 2019$20.44$20.31$23.68
27 Dec 2019$20.27$20.43$23.48
17 Jan 2020$18.91$20.30$23.12
7 Feb 2020$17.04$19.46$22.63
28 Feb 2020$15.55$18.35$22.04
20 Mar 2020$10.58$16.19$21.17
9 Apr 2020$13.21$14.31$20.13
1 May 2020$12.07$13.19$19.04
22 May 2020$12.70$12.36$18.12
12 Jun 2020$13.01$13.07$17.52
2 Jul 2020$14.56$13.43$16.90
24 Jul 2020$15.79$14.12$16.28
14 Aug 2020$13.54$14.34$15.89
4 Sep 2020$13.02$14.09$15.31
25 Sep 2020$12.20$13.57$14.76
16 Oct 2020$13.35$13.10$14.21
6 Nov 2020$11.27$12.64$13.68
27 Nov 2020$13.17$12.46$13.33
18 Dec 2020$14.85$12.85$13.18
8 Jan 2021$14.82$13.21$13.35
29 Jan 2021$16.27$14.46$13.60
19 Feb 2021$19.37$16.08$14.00
12 Mar 2021$19.65$17.44$14.49
1 Apr 2021$21.00$18.94$14.91
23 Apr 2021$22.27$20.15$15.46
14 May 2021$21.12$21.05$15.97
4 Jun 2021$24.59$21.78$16.59
25 Jun 2021$27.20$23.02$17.48
16 Jul 2021$25.55$24.36$18.51
6 Aug 2021$26.81$25.93$19.48
27 Aug 2021$25.69$26.16$20.50
17 Sep 2021$25.60$25.87$21.43
8 Oct 2021$23.73$25.76$22.29
29 Oct 2021$23.39$24.96$22.93
19 Nov 2021$28.69$25.69$23.82
10 Dec 2021$27.20$26.11$24.38
31 Dec 2021$28.89$27.35$25.02
21 Jan 2022$25.23$27.90$25.46
11 Feb 2022$28.47$27.16$25.78
4 Mar 2022$52.30$30.40$26.98
25 Mar 2022$49.90$37.72$29.20
14 Apr 2022$60.28$46.68$31.44
6 May 2022$64.20$56.60$34.08
27 May 2022$70.34$60.20$36.86
17 Jun 2022$60.72$63.43$39.77
8 Jul 2022$67.79$64.42$42.21
29 Jul 2022$76.72$66.82$45.61
19 Aug 2022$82.47$70.54$49.87
9 Sep 2022$85.05$75.71$53.53
30 Sep 2022$70.33$78.08$57.13
21 Oct 2022$72.33$76.67$60.33
11 Nov 2022$56.47$72.02$63.34
2 Dec 2022$61.27$65.94$65.55
23 Dec 2022$50.63$60.93$66.25
13 Jan 2023$53.08$54.98$66.02
3 Feb 2023$60.80$54.37$65.85
24 Feb 2023$72.41$55.21$65.78
17 Mar 2023$77.84$61.80$66.49
6 Apr 2023$83.10$69.99$67.54
28 Apr 2023$85.45$78.84$69.32
19 May 2023$97.24$86.39$70.96
9 Jun 2023$85.97$90.02$71.64
30 Jun 2023$83.92$90.56$72.03
21 Jul 2023$87.54$89.49$72.84
11 Aug 2023$69.00$84.20$73.38
1 Sep 2023$67.30$77.76$73.51
22 Sep 2023$61.82$72.13$73.90
13 Oct 2023$67.47$67.19$75.08
3 Nov 2023$64.32$66.78$76.29
24 Nov 2023$68.82$66.85$76.93
15 Dec 2023$76.04$68.91$77.59
5 Jan 2024$64.49$66.79$76.70
26 Jan 2024$52.88$64.44$74.87
16 Feb 2024$57.46$59.90$72.42
8 Mar 2024$62.52$58.84$70.15
28 Mar 2024$62.24$58.47$68.04
19 Apr 2024$63.81$60.65$66.05
10 May 2024$76.02$63.64$64.94
31 May 2024$81.83$68.92$65.24
21 Jun 2024$79.10$74.84$66.24
12 Jul 2024$123.42$81.61$67.88
2 Aug 2024$97.59$92.17$71.15
23 Aug 2024$107.16$97.46$73.51
13 Sep 2024$105.55$104.36$76.17
4 Oct 2024$107.78$103.89$78.85
25 Oct 2024$110.30$107.09$82.55
15 Nov 2024$76.83$104.95$85.77
6 Dec 2024$89.02$99.73$87.94
27 Dec 2024$92.07$95.01$89.88
17 Jan 2025$91.47$90.06$92.05
7 Feb 2025$88.71$91.95$94.29
28 Feb 2025$93.82$90.13$95.19
21 Mar 2025$97.71$93.04$96.78
11 Apr 2025$102.00$94.01$98.03
2 May 2025$108.74$98.74$98.69
23 May 2025$73.86$94.78$96.63
13 Jun 2025$77.83$88.98$95.21
3 Jul 2025$80.42$84.09$93.61
25 Jul 2025$72.93$78.24$91.29
15 Aug 2025$54.18$73.93$87.65
5 Sep 2025$54.75$67.17$84.69
26 Sep 2025$50.61$58.71$82.09
17 Oct 2025$55.60$53.95$79.23
7 Nov 2025$51.07$54.09$76.45
28 Nov 2025$58.87$54.42$73.94
19 Dec 2025$65.92$57.74$72.08
9 Jan 2026$67.56$60.71$69.84
30 Jan 2026$66.92$64.08$67.68
20 Feb 2026$73.87$66.95$65.24
13 Mar 2026$79.49$70.53$65.04
2 Apr 2026$76.10$73.18$64.89
24 Apr 2026$84.33$77.77$64.99
15 May 2026$93.91$82.34$66.06
5 Jun 2026$100.98$87.89$68.77
26 Jun 2026$109.80$95.21$72.18
17 Jul 2026$107.59$101.46$76.00
7 Aug 2026$100.95$103.79$79.67
28 Aug 2026$100.77$103.62$83.02
18 Sep 2026$100.55$101.84$86.20
9 Oct 2026$100.15$100.47$88.93
30 Oct 2026$100.46$100.26$91.38
4 Nov 2026$101.14$100.27$91.91
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 10-year window.

Price stage: Falling from Oct 2025 to Feb 2026; Sideways from Feb 2026 to Jul 2026; Rising from Jul 2026 to Nov 2026.

Price stage: Sideways from Nov 2023 to Feb 2024; Falling from Feb 2024 to Apr 2024; Sideways from May 2024 to Aug 2024; Rising from Sep 2024 to Jan 2025; Sideways from Jan 2025 to Feb 2025; Rising from Mar 2025 to May 2025; Sideways from May 2025 to Aug 2025; Falling from Aug 2025 to Feb 2026; Sideways from Feb 2026 to Jul 2026; Rising from Jul 2026 to Nov 2026.

Price stage: Rising from Oct 2021 to Oct 2022; Sideways from Nov 2022 to Feb 2023; Rising from Mar 2023 to Aug 2023; Sideways from Aug 2023 to Feb 2024; Falling from Mar 2024 to Apr 2024; Sideways from May 2024 to Aug 2024; Rising from Sep 2024 to Jan 2025; Sideways from Jan 2025 to Aug 2025; Falling from Aug 2025 to Jan 2026; Sideways from Feb 2026 to Jul 2026; Rising from Jul 2026 to Nov 2026.

Price stage: Rising from Dec 2017 to Feb 2018; Sideways from Mar 2018 to Aug 2018; Falling from Aug 2018 to Nov 2018; Sideways from Nov 2018 to Mar 2019; Rising from Apr 2019 to Sep 2019; Sideways from Oct 2019 to Feb 2020; Falling from Mar 2020 to Nov 2020; Sideways from Dec 2020 to Apr 2021; Rising from Apr 2021 to Oct 2022; Sideways from Nov 2022 to Feb 2023; Rising from Feb 2023 to Jul 2023; Sideways from Aug 2023 to Feb 2024; Falling from Mar 2024 to Apr 2024; Sideways from May 2024 to Aug 2024; Rising from Sep 2024 to Dec 2024; Sideways from Jan 2025 to Feb 2025; Rising from Mar 2025 to May 2025; Sideways from May 2025 to Jul 2025; Falling from Aug 2025 to Jan 2026; Sideways from Feb 2026 to Jun 2026; Rising from Jul 2026 to Nov 2026.

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?

Ahead in 286 of 527 weeks

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
8 Jul 2016no S&P 500 reading
15 Jul 2016no S&P 500 reading
22 Jul 2016no S&P 500 reading
29 Jul 2016no S&P 500 reading
5 Aug 2016no S&P 500 reading
12 Aug 2016no S&P 500 reading
19 Aug 2016no S&P 500 reading
26 Aug 2016no S&P 500 reading
2 Sep 2016no S&P 500 reading
9 Sep 2016no S&P 500 reading
16 Sep 2016no S&P 500 reading
23 Sep 2016no S&P 500 reading
30 Sep 2016no S&P 500 reading
7 Oct 2016+76.9%
14 Oct 2016+62.7%
21 Oct 2016+112.0%
28 Oct 2016+93.9%
4 Nov 2016+51.1%
11 Nov 2016+53.6%
18 Nov 2016+17.3%
25 Nov 2016+16.2%
2 Dec 2016−3.3%
9 Dec 2016+20.8%
16 Dec 2016−0.3%
23 Dec 2016−3.8%
30 Dec 2016+0.5%
6 Jan 2017−6.0%
13 Jan 2017+10.3%
20 Jan 2017−4.9%
27 Jan 2017+0.9%
3 Feb 2017−8.8%
10 Feb 2017−12.0%
17 Feb 2017−5.4%
24 Feb 2017+22.9%
3 Mar 2017+37.9%
10 Mar 2017+35.3%
17 Mar 2017+36.5%
24 Mar 2017+35.6%
31 Mar 2017+39.9%
7 Apr 2017+45.0%
13 Apr 2017+18.2%
21 Apr 2017+23.3%
28 Apr 2017+42.9%
5 May 2017+48.3%
12 May 2017+73.2%
19 May 2017+71.1%
26 May 2017+32.7%
2 Jun 2017+22.6%
9 Jun 2017+18.7%
16 Jun 2017+18.9%
23 Jun 2017+27.1%
30 Jun 2017+38.6%
7 Jul 2017+44.0%
14 Jul 2017+56.1%
21 Jul 2017+54.7%
28 Jul 2017+46.7%
4 Aug 2017+23.3%
11 Aug 2017+13.9%
18 Aug 2017−4.6%
25 Aug 2017−0.9%
1 Sep 2017−1.2%
8 Sep 2017+1.5%
15 Sep 2017+10.9%
22 Sep 2017+8.6%
29 Sep 2017−3.1%
6 Oct 2017−4.2%
13 Oct 2017−2.1%
20 Oct 2017−5.8%
27 Oct 2017−5.7%
3 Nov 2017+25.2%
10 Nov 2017+10.5%
17 Nov 2017+34.8%
24 Nov 2017+26.3%
1 Dec 2017+23.4%
8 Dec 2017+18.7%
15 Dec 2017+7.9%
22 Dec 2017+11.2%
29 Dec 2017+8.7%
5 Jan 2018+12.1%
12 Jan 2018+22.5%
19 Jan 2018+15.9%
26 Jan 2018+11.1%
2 Feb 2018−8.4%
9 Feb 2018−11.7%
16 Feb 2018−14.0%
23 Feb 2018−18.3%
2 Mar 2018−26.7%
9 Mar 2018−28.3%
16 Mar 2018−20.7%
23 Mar 2018−21.0%
29 Mar 2018−20.9%
6 Apr 2018−24.3%
13 Apr 2018−27.5%
20 Apr 2018−18.1%
27 Apr 2018−16.7%
4 May 2018−21.6%
11 May 2018−29.7%
18 May 2018−30.0%
25 May 2018−25.6%
1 Jun 2018−12.7%
8 Jun 2018−11.6%
15 Jun 2018−11.6%
22 Jun 2018−8.7%
29 Jun 2018−11.6%
6 Jul 2018−8.7%
13 Jul 2018−17.4%
20 Jul 2018−26.8%
27 Jul 2018−31.7%
3 Aug 2018−23.8%
10 Aug 2018−15.9%
17 Aug 2018−10.7%
24 Aug 2018−5.6%
31 Aug 2018+4.2%
7 Sep 2018+5.8%
14 Sep 2018+7.8%
21 Sep 2018−3.0%
28 Sep 2018−4.4%
5 Oct 2018−9.6%
12 Oct 2018−4.2%
19 Oct 2018−0.2%
26 Oct 2018+2.7%
2 Nov 2018+14.9%
9 Nov 2018+16.1%
16 Nov 2018+24.8%
23 Nov 2018+19.4%
30 Nov 2018+21.5%
7 Dec 2018+18.4%
14 Dec 2018+16.2%
21 Dec 2018+10.5%
28 Dec 2018+15.3%
4 Jan 2019+23.0%
11 Jan 2019+28.6%
18 Jan 2019+26.3%
25 Jan 2019+31.1%
1 Feb 2019+12.5%
8 Feb 2019+19.4%
15 Feb 2019+12.8%
22 Feb 2019+42.2%
1 Mar 2019+24.9%
8 Mar 2019+34.3%
15 Mar 2019+31.4%
22 Mar 2019+46.3%
29 Mar 2019+48.9%
5 Apr 2019+49.1%
12 Apr 2019+45.1%
18 Apr 2019+36.9%
26 Apr 2019+38.2%
3 May 2019+45.8%
10 May 2019+39.4%
17 May 2019+27.7%
24 May 2019+2.0%
31 May 2019+2.8%
7 Jun 2019+3.2%
14 Jun 2019+6.9%
21 Jun 2019+12.6%
28 Jun 2019+11.9%
5 Jul 2019+8.5%
12 Jul 2019+5.1%
19 Jul 2019+14.6%
26 Jul 2019−12.5%
2 Aug 2019−13.3%
9 Aug 2019−12.1%
16 Aug 2019−5.8%
23 Aug 2019−12.1%
30 Aug 2019−15.5%
6 Sep 2019−14.7%
13 Sep 2019−11.0%
20 Sep 2019−6.7%
27 Sep 2019−11.3%
4 Oct 2019−29.9%
11 Oct 2019−30.1%
18 Oct 2019−33.5%
25 Oct 2019−14.4%
1 Nov 2019−12.4%
8 Nov 2019−11.5%
15 Nov 2019−14.7%
22 Nov 2019−16.9%
29 Nov 2019−11.4%
6 Dec 2019−14.8%
13 Dec 2019−23.1%
20 Dec 2019−29.0%
27 Dec 2019−29.2%
3 Jan 2020−12.3%
10 Jan 2020−9.0%
17 Jan 2020−11.1%
24 Jan 2020−16.4%
31 Jan 2020−20.7%
7 Feb 2020−28.1%
14 Feb 2020−31.0%
21 Feb 2020−25.3%
28 Feb 2020−19.9%
6 Mar 2020−20.7%
13 Mar 2020−21.1%
20 Mar 2020−20.3%
27 Mar 2020−18.7%
3 Apr 2020−23.1%
9 Apr 2020−16.5%
17 Apr 2020−13.1%
24 Apr 2020−10.4%
1 May 2020−19.0%
8 May 2020−12.3%
15 May 2020−13.1%
22 May 2020−11.9%
29 May 2020−14.4%
5 Jun 2020−10.4%
12 Jun 2020−12.3%
19 Jun 2020+5.3%
26 Jun 2020−8.5%
2 Jul 2020+15.0%
10 Jul 2020−5.0%
17 Jul 2020+1.5%
24 Jul 2020+2.4%
31 Jul 2020−3.8%
7 Aug 2020−11.4%
14 Aug 2020−4.2%
21 Aug 2020−11.4%
28 Aug 2020−16.9%
4 Sep 2020−18.2%
11 Sep 2020−13.2%
18 Sep 2020−20.0%
25 Sep 2020−18.0%
2 Oct 2020−18.4%
9 Oct 2020−16.1%
16 Oct 2020−23.2%
23 Oct 2020−25.9%
30 Oct 2020−19.4%
6 Nov 2020−19.9%
13 Nov 2020−16.5%
20 Nov 2020−9.5%
27 Nov 2020−6.1%
4 Dec 2020−2.4%
11 Dec 2020+6.7%
18 Dec 2020+3.3%
24 Dec 2020+8.6%
31 Dec 2020−7.3%
8 Jan 2021+0.5%
15 Jan 2021+7.4%
22 Jan 2021+12.7%
29 Jan 2021+36.5%
5 Feb 2021+56.1%
12 Feb 2021+54.8%
19 Feb 2021+45.1%
26 Feb 2021+37.2%
5 Mar 2021+35.0%
12 Mar 2021+26.8%
19 Mar 2021+29.5%
26 Mar 2021+27.0%
1 Apr 2021+48.5%
9 Apr 2021+34.0%
16 Apr 2021+29.6%
23 Apr 2021+30.7%
30 Apr 2021+32.9%
7 May 2021+8.0%
14 May 2021−0.5%
21 May 2021+4.8%
28 May 2021+19.4%
4 Jun 2021+18.9%
11 Jun 2021+16.0%
18 Jun 2021+16.3%
25 Jun 2021+29.6%
2 Jul 2021+27.5%
9 Jul 2021+23.0%
16 Jul 2021+14.4%
23 Jul 2021+9.7%
30 Jul 2021+5.3%
6 Aug 2021+17.2%
13 Aug 2021+13.8%
20 Aug 2021+9.2%
27 Aug 2021−1.3%
3 Sep 2021+3.2%
10 Sep 2021+1.9%
17 Sep 2021−2.4%
24 Sep 2021−4.9%
1 Oct 2021−9.4%
8 Oct 2021−13.0%
15 Oct 2021−12.3%
22 Oct 2021−14.5%
29 Oct 2021−15.4%
5 Nov 2021+2.0%
12 Nov 2021+14.5%
19 Nov 2021+9.0%
26 Nov 2021+6.6%
3 Dec 2021−2.5%
10 Dec 2021−0.9%
17 Dec 2021+1.8%
23 Dec 2021+3.0%
31 Dec 2021+2.3%
7 Jan 2022+6.9%
14 Jan 2022+13.1%
21 Jan 2022+14.4%
28 Jan 2022+9.7%
4 Feb 2022−3.9%
11 Feb 2022−0.7%
18 Feb 2022+7.9%
25 Feb 2022+71.8%
4 Mar 2022+102.0%
11 Mar 2022+101.3%
18 Mar 2022+105.9%
25 Mar 2022+73.5%
1 Apr 2022+106.6%
8 Apr 2022+127.8%
14 Apr 2022+126.7%
22 Apr 2022+133.9%
29 Apr 2022+174.9%
6 May 2022+150.0%
13 May 2022+133.6%
20 May 2022+126.2%
27 May 2022+56.0%
3 Jun 2022+42.5%
10 Jun 2022+30.4%
17 Jun 2022+28.2%
24 Jun 2022+39.7%
1 Jul 2022+24.6%
8 Jul 2022+25.8%
15 Jul 2022+29.2%
22 Jul 2022+25.0%
29 Jul 2022+15.5%
5 Aug 2022+21.9%
12 Aug 2022+23.6%
19 Aug 2022+24.1%
26 Aug 2022+18.3%
2 Sep 2022+13.6%
9 Sep 2022+28.9%
16 Sep 2022+25.6%
23 Sep 2022+14.5%
30 Sep 2022+17.1%
7 Oct 2022+3.2%
14 Oct 2022+4.6%
21 Oct 2022+10.6%
28 Oct 2022+3.9%
4 Nov 2022−13.9%
11 Nov 2022−25.4%
18 Nov 2022−23.9%
25 Nov 2022−27.6%
2 Dec 2022−25.7%
9 Dec 2022−34.0%
16 Dec 2022−32.7%
23 Dec 2022−30.0%
30 Dec 2022−34.6%
6 Jan 2023−32.9%
13 Jan 2023−34.3%
20 Jan 2023−31.9%
27 Jan 2023−29.8%
3 Feb 2023−9.2%
10 Feb 2023+0.8%
17 Feb 2023+0.7%
24 Feb 2023+25.4%
3 Mar 2023+19.7%
10 Mar 2023+35.5%
17 Mar 2023+45.1%
24 Mar 2023+57.5%
31 Mar 2023+55.0%
6 Apr 2023+66.0%
14 Apr 2023+63.5%
21 Apr 2023+65.5%
28 Apr 2023+49.5%
5 May 2023+54.6%
12 May 2023+70.1%
19 May 2023+60.0%
26 May 2023+19.8%
2 Jun 2023+15.7%
9 Jun 2023+9.2%
16 Jun 2023+0.7%
23 Jun 2023+4.2%
30 Jun 2023−6.6%
7 Jul 2023−8.0%
14 Jul 2023−11.8%
21 Jul 2023−13.1%
28 Jul 2023−6.9%
4 Aug 2023−27.8%
11 Aug 2023−39.0%
18 Aug 2023−36.1%
25 Aug 2023−31.9%
1 Sep 2023−29.5%
8 Sep 2023−26.4%
15 Sep 2023−27.5%
22 Sep 2023−32.5%
29 Sep 2023−13.6%
6 Oct 2023−12.0%
13 Oct 2023−17.7%
20 Oct 2023−13.6%
27 Oct 2023−13.9%
3 Nov 2023−12.3%
10 Nov 2023−6.9%
17 Nov 2023−0.4%
24 Nov 2023+0.2%
1 Dec 2023+7.9%
8 Dec 2023+7.7%
15 Dec 2023+11.5%
22 Dec 2023−13.7%
29 Dec 2023−22.0%
5 Jan 2024−17.9%
12 Jan 2024−27.1%
19 Jan 2024−38.3%
26 Jan 2024−39.6%
2 Feb 2024−29.8%
9 Feb 2024−25.3%
16 Feb 2024−26.6%
23 Feb 2024−15.2%
1 Mar 2024−24.1%
8 Mar 2024−26.4%
15 Mar 2024−32.1%
22 Mar 2024−11.0%
28 Mar 2024−9.7%
5 Apr 2024−16.5%
12 Apr 2024+0.9%
19 Apr 2024+17.6%
26 Apr 2024+19.7%
3 May 2024+36.4%
10 May 2024+31.5%
17 May 2024+32.7%
24 May 2024+13.8%
31 May 2024+23.8%
7 Jun 2024+23.4%
14 Jun 2024+29.8%
21 Jun 2024+29.6%
28 Jun 2024+25.0%
5 Jul 2024+22.7%
12 Jul 2024+93.4%
19 Jul 2024+72.2%
26 Jul 2024+64.8%
2 Aug 2024+25.0%
9 Aug 2024+25.7%
16 Aug 2024+14.4%
23 Aug 2024+30.8%
30 Aug 2024+23.2%
6 Sep 2024+26.4%
13 Sep 2024+29.6%
20 Sep 2024+34.8%
27 Sep 2024+28.7%
4 Oct 2024+33.3%
11 Oct 2024−12.6%
18 Oct 2024−6.6%
25 Oct 2024−8.5%
1 Nov 2024+3.5%
8 Nov 2024−22.3%
15 Nov 2024−24.7%
22 Nov 2024−21.5%
29 Nov 2024−23.1%
6 Dec 2024−25.2%
13 Dec 2024−19.4%
20 Dec 2024−22.9%
27 Dec 2024−18.4%
3 Jan 2025−18.7%
10 Jan 2025−14.7%
17 Jan 2025−23.8%
24 Jan 2025−16.6%
31 Jan 2025−19.7%
7 Feb 2025+1.0%
14 Feb 2025+0.0%
21 Feb 2025−14.3%
28 Feb 2025+6.5%
7 Mar 2025+24.7%
14 Mar 2025+15.5%
21 Mar 2025+14.0%
28 Mar 2025+11.1%
4 Apr 2025+14.3%
11 Apr 2025+14.4%
17 Apr 2025+22.7%
25 Apr 2025+13.8%
2 May 2025+23.4%
9 May 2025−1.8%
16 May 2025+4.2%
23 May 2025−2.1%
30 May 2025−18.7%
6 Jun 2025−27.3%
13 Jun 2025−29.1%
20 Jun 2025−24.3%
27 Jun 2025−25.9%
3 Jul 2025−35.3%
11 Jul 2025−37.1%
18 Jul 2025−50.0%
25 Jul 2025−44.0%
1 Aug 2025−44.8%
8 Aug 2025−42.9%
15 Aug 2025−41.6%
22 Aug 2025−32.6%
29 Aug 2025−36.8%
5 Sep 2025−40.9%
12 Sep 2025−42.1%
19 Sep 2025−48.0%
26 Sep 2025−45.5%
3 Oct 2025−40.1%
10 Oct 2025−38.9%
17 Oct 2025−26.6%
24 Oct 2025−29.4%
31 Oct 2025−28.0%
7 Nov 2025−16.0%
14 Nov 2025−6.6%
21 Nov 2025−6.2%
28 Nov 2025+1.3%
5 Dec 2025+9.7%
12 Dec 2025+22.1%
19 Dec 2025+28.2%
26 Dec 2025+27.5%
2 Jan 2026+22.9%
9 Jan 2026+19.9%
16 Jan 2026+11.5%
23 Jan 2026+18.7%
30 Jan 2026+14.5%
6 Feb 2026+24.1%
13 Feb 2026+29.4%
20 Feb 2026+27.7%
27 Feb 2026+26.9%
6 Mar 2026+16.6%
13 Mar 2026+22.2%
20 Mar 2026+20.6%
27 Mar 2026+19.8%
2 Apr 2026+17.1%
10 Apr 2026+21.4%
17 Apr 2026+27.8%
24 Apr 2026+21.3%
1 May 2026+23.6%
8 May 2026+36.6%
15 May 2026+26.9%
22 May 2026+31.3%
29 May 2026+22.3%
5 Jun 2026+29.5%
12 Jun 2026+19.5%
18 Jun 2026+20.8%
26 Jun 2026+32.5%
2 Jul 2026+30.8%
10 Jul 2026+20.0%
17 Jul 2026+23.7%
24 Jul 2026+20.8%
31 Jul 2026+12.9%
7 Aug 2026+3.6%
14 Aug 2026+2.5%
21 Aug 2026−5.6%
28 Aug 2026−0.2%
4 Sep 2026−4.4%
11 Sep 2026−7.1%
18 Sep 2026−5.2%
25 Sep 2026−15.0%
2 Oct 2026−12.4%
9 Oct 2026−8.3%
16 Oct 2026−10.0%
23 Oct 2026−7.6%
30 Oct 2026−0.3%
4 Nov 2026+1.0%
Each bar is one week, from 2016 to now (527 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 10 years the share price moved +2,075% while the S&P 500 moved +261%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does Lantheus Holdings pay?

Lantheus Holdings, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes.

Which stock lists is Lantheus Holdings on?

Lantheus Holdings is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is Lantheus Holdings profitable?

Lantheus Holdings, Inc. earned $75.0 M of net profit in the Jun 2026 quarter, −4.7% on the same quarter a year earlier. Full-year FY25 profit was $234 M. That is 19.3% of the quarter's revenue. The same quarter a year earlier earned $78.8 M. 1 of the last 12 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY25 profit was $234 M (−25.2% on the year before).

FY25 profit $234 M (−25.2% on the year before)

  • Net profit $234 M
FY25 profit $234 M (−25.2% on the year before)
QuarterNet profit
FY21−$71.3 M
FY22$28.1 M
FY23$327 M
FY24$312 M
FY25$234 M

Growth on a year earlier

  • Growth on a year earlier −25.2%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY22–
FY231,063.9%
FY24−4.4%
FY25−25.2%
Top: net profit each year, $ M. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $75.0 M (−4.7% on a year earlier)

  • Net profit (quarterly) $75.0 M
Jun 2026: $75.0 M (−4.7% on a year earlier)
QuarterNet profit (quarterly)
Sep 2023$132 M
Dec 2023$103 M
Mar 2024$131 M
Jun 2024$62.1 M
Sep 2024$131 M
Dec 2024−$11.8 M
Mar 2025$72.9 M
Jun 2025$78.8 M
Sep 2025$27.8 M
Dec 2025$54.1 M
Mar 2026$118 M
Jun 2026$75.0 M

Growth on a year earlier

  • Growth on a year earlier −4.7%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 2023115.5%
Dec 2023–
Mar 2024–
Jun 2024−34.1%
Sep 2024−0.7%
Dec 2024−111.4%
Mar 2025−44.3%
Jun 202526.9%
Sep 2025−78.8%
Dec 2025–
Mar 202662.3%
Jun 2026−4.7%
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Why profit moved: revenue changed +2.7% on a year earlier and the margin moved +2.5 percentage points. Most of the change came from keeping more of each sale.

On average over the last four quarters, profit changed −7.1% and revenue +2.3%. Profit is growing slower than sales: rising costs are taking part of the growth.

How much revenue does Lantheus Holdings make, and is it growing?

Lantheus Holdings, Inc. reported $388 M of revenue in the Jun 2026 quarter, +2.7% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 4 years it has grown 38.0% a year on average. The last full year, FY25, came in at $1.5 B.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $1.6 B.

FY25 revenue was $1.5 B, +0.5% on the year before.

FY25 revenue $1.5 B (+0.5% on the year before), 38.0% a year over 4 years

  • Revenue $1.5 B
FY25 revenue $1.5 B (+0.5% on the year before), 38.0% a year over 4 years
QuarterRevenue
FY21$425 M
FY22$935 M
FY23$1.3 B
FY24$1.5 B
FY25$1.5 B

Growth on a year earlier

  • Growth on a year earlier 0.5%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY22119.9%
FY2338.6%
FY2418.3%
FY250.5%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $388 M (+2.7% on a year earlier), the 4th quarter in a row of growth

  • Revenue (quarterly) $388 M
Jun 2026: $388 M (+2.7% on a year earlier), the 4th quarter in a row of growth
QuarterRevenue (quarterly)
Sep 2023$320 M
Dec 2023$354 M
Mar 2024$370 M
Jun 2024$394 M
Sep 2024$379 M
Dec 2024$391 M
Mar 2025$373 M
Jun 2025$378 M
Sep 2025$384 M
Dec 2025$407 M
Mar 2026$377 M
Jun 2026$388 M

Growth on a year earlier

  • Growth on a year earlier 2.7%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 202333.7%
Dec 202334.5%
Mar 202423%
Jun 202422.5%
Sep 202418.4%
Dec 202410.5%
Mar 20250.8%
Jun 2025−4.1%
Sep 20251.4%
Dec 20254%
Mar 20261.2%
Jun 20262.7%
Top: revenue each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +2.3% on average, against 38.0% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +2.3%, against +4.0% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +1.6%, against −19.8% a year (accelerating).

How much of every $100 of sales does Lantheus Holdings keep?

Lantheus Holdings, Inc.'s operating margin was 25.8% in the Jun 2026 quarter, 2.5 percentage points higher than the same quarter a year ago. Across 5 years it has been between −15.7% and 29.1%. The latest quarter is within that range.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +2.5 percentage points on the year while gross margin changed −1.5 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

FY25: 20.3%, within a range of −15.7% to 29.1% over 5 years

  • Operating margin 20.3%
FY25: 20.3%, within a range of −15.7% to 29.1% over 5 years
QuarterOperating margin
FY21−15.7%
FY223.9%
FY2328.6%
FY2429.1%
FY2520.3%

Change on the year before (points)

  • Change on the year before (points) −8.8 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22+19.6 pts
FY23+24.7 pts
FY24+0.5 pts
FY25−8.8 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jun 2026: operating margin 25.8% (+2.5 points on a year earlier)

  • Operating margin 25.8%
Jun 2026: operating margin 25.8% (+2.5 points on a year earlier)
QuarterOperating margin
Sep 202335.1%
Dec 202338.9%
Mar 202427.1%
Jun 202426.1%
Sep 202435.3%
Dec 202427.9%
Mar 202528.6%
Jun 202523.3%
Sep 202511.4%
Dec 202519.1%
Mar 202621.6%
Jun 202625.8%

Change on a year earlier (points)

  • Change on a year earlier (points) +2.5 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Sep 2023−0.7 pts
Dec 2023+104.1 pts
Mar 2024−13.7 pts
Jun 2024−12.5 pts
Sep 2024+0.2 pts
Dec 2024−11.0 pts
Mar 2025+1.5 pts
Jun 2025−2.8 pts
Sep 2025−23.9 pts
Dec 2025−8.8 pts
Mar 2026−7.0 pts
Jun 2026+2.5 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is Lantheus Holdings' profit turning into cash?

Over the last 3 years, 142% of Lantheus Holdings, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $390 M of operating cash against $234 M of profit. After $36.1 M of spending on assets, $354 M was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $390 M against profit $234 M; 142% of 3 years' profit came in as cash

  • Operating cash $390 M
  • Net profit $234 M
  • Free cash $354 M
FY25: operating cash $390 M against profit $234 M; 142% of 3 years' profit came in as cash
QuarterOperating cashNet profitFree cash
FY21$53.9 M−$71.3 M$41.8 M
FY22$282 M$28.1 M$3.4 M
FY23$305 M$327 M$213 M
FY24$545 M$312 M$412 M
FY25$390 M$234 M$354 M
Operating cash flow and net profit each year, $ M. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Jun 2026: operating cash $92.2 M = 123% of the quarter's profit

  • Operating cash (quarterly) $92.2 M
Jun 2026: operating cash $92.2 M = 123% of the quarter's profit
QuarterOperating cash (quarterly)
Sep 2023$117 M
Dec 2023$112 M
Mar 2024$127 M
Jun 2024$84.7 M
Sep 2024$175 M
Dec 2024$158 M
Mar 2025$108 M
Jun 2025$87.1 M
Sep 2025$105 M
Dec 2025$90.2 M
Mar 2026$125 M
Jun 2026$92.2 M

Operating cash as % of profit

  • Operating cash as % of profit 123%
Operating cash as % of profit
QuarterOperating cash as % of profit
Sep 202388%
Dec 2023109%
Mar 202497%
Jun 2024136%
Sep 2024134%
Dec 2024–
Mar 2025147%
Jun 2025111%
Sep 2025379%
Dec 2025167%
Mar 2026106%
Jun 2026123%
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Where does Lantheus Holdings' cash go?

Lantheus Holdings, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $261 M on assets over the last 3 years. Averaged over those years that is 5.6% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $261 M over the last 3 years.

FY25: capex $36.1 M, down from the year before

  • Capex $36.1 M
FY25: capex $36.1 M, down from the year before
QuarterCapex
FY21$12.1 M
FY22$278 M
FY23$91.9 M
FY24$133 M
FY25$36.1 M
Capital spending each year, $ M.

Jun 2026: capex $2.3 M in the quarter

  • Capex (quarterly) $2.3 M
Jun 2026: capex $2.3 M in the quarter
QuarterCapex (quarterly)
Sep 2023$14.6 M
Dec 2023$12.1 M
Mar 2024$8.3 M
Jun 2024$45.1 M
Sep 2024$62.8 M
Dec 2024$16.4 M
Mar 2025$8.7 M
Jun 2025$8.0 M
Sep 2025$10.6 M
Dec 2025$8.8 M
Mar 2026$3.2 M
Jun 2026$2.3 M

Free cash

  • Free cash $89.9 M
Free cash
QuarterFree cash
Sep 2023$102 M
Dec 2023$100 M
Mar 2024$119 M
Jun 2024$39.6 M
Sep 2024$112 M
Dec 2024$141 M
Mar 2025$98.8 M
Jun 2025$79.1 M
Sep 2025$94.7 M
Dec 2025$81.4 M
Mar 2026$122 M
Jun 2026$89.9 M
Top: capital spending each quarter, $ M. Below: free cash flow, $ M. Last 12 quarters.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

What is Lantheus Holdings' P/E ratio, and how does it compare with its own history?

Lantheus Holdings, Inc.'s P/E is 24.4×, in the middle of its own history: higher than 54% of past readings. Its usual P/E (the middle reading) is 24.1×, over 4.3 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

P/E 24.4× against a usual 24.1×: in the middle of its own history: higher than 54% of past readings

  • P/E 24.5×
  • Median 24.1×
P/E 24.4× against a usual 24.1×: in the middle of its own history: higher than 54% of past readings
WeekP/EMedian
1 Jul 202272.4×24.1×
8 Jul 202272.4×24.1×
15 Jul 202272.4×24.1×
22 Jul 202272.4×24.1×
29 Jul 202272.4×24.1×
5 Aug 202272.4×24.1×
12 Aug 202272.4×24.1×
19 Aug 202272.4×24.1×
26 Aug 202272.4×24.1×
2 Sep 202272.4×24.1×
9 Sep 202272.4×24.1×
16 Sep 202272.4×24.1×
23 Sep 202272.4×24.1×
30 Sep 202247.5×24.1×
7 Oct 202244.2×24.1×
14 Oct 202246.5×24.1×
21 Oct 202248.8×24.1×
28 Oct 202251.0×24.1×
4 Nov 202240.9×24.1×
11 Nov 202238.1×24.1×
18 Nov 202239.0×24.1×
25 Nov 202239.5×24.1×
2 Dec 202241.4×24.1×
9 Dec 202236.0×24.1×
16 Dec 202235.8×24.1×
23 Dec 202234.2×24.1×
30 Dec 202234.4×24.1×
6 Jan 202372.4×24.1×
13 Jan 202372.4×24.1×
20 Jan 202372.4×24.1×
27 Jan 202372.4×24.1×
3 Feb 202372.4×24.1×
10 Feb 202372.4×24.1×
17 Feb 202372.4×24.1×
24 Feb 202372.4×24.1×
3 Mar 202372.4×24.1×
10 Mar 202372.4×24.1×
17 Mar 202372.4×24.1×
24 Mar 202372.4×24.1×
31 Mar 202372.4×24.1×
6 Apr 202372.4×24.1×
14 Apr 202372.4×24.1×
21 Apr 202372.4×24.1×
28 Apr 202372.4×24.1×
5 May 202372.4×24.1×
12 May 202372.4×24.1×
19 May 202372.4×24.1×
26 May 202372.4×24.1×
2 Jun 202372.4×24.1×
9 Jun 202372.4×24.1×
16 Jun 202372.4×24.1×
23 Jun 202372.4×24.1×
30 Jun 202372.4×24.1×
7 Jul 202372.4×24.1×
14 Jul 202372.4×24.1×
21 Jul 202372.4×24.1×
28 Jul 202372.4×24.1×
4 Aug 202372.4×24.1×
11 Aug 202372.4×24.1×
18 Aug 202372.4×24.1×
25 Aug 202372.4×24.1×
1 Sep 202372.4×24.1×
8 Sep 202372.4×24.1×
15 Sep 202372.4×24.1×
22 Sep 202372.4×24.1×
29 Sep 202372.4×24.1×
6 Oct 202349.6×24.1×
13 Oct 202347.2×24.1×
20 Oct 202348.7×24.1×
27 Oct 202346.8×24.1×
3 Nov 202345.0×24.1×
10 Nov 202344.4×24.1×
17 Nov 202347.7×24.1×
24 Nov 202348.2×24.1×
1 Dec 202351.6×24.1×
8 Dec 202351.6×24.1×
15 Dec 202353.2×24.1×
22 Dec 202341.7×24.1×
29 Dec 202343.4×24.1×
5 Jan 202413.9×24.1×
12 Jan 202412.1×24.1×
19 Jan 202411.4×24.1×
26 Jan 202411.4×24.1×
2 Feb 202411.6×24.1×
9 Feb 202412.1×24.1×
16 Feb 202412.4×24.1×
23 Feb 202414.3×24.1×
1 Mar 202413.9×24.1×
8 Mar 202413.5×24.1×
15 Mar 202412.5×24.1×
22 Mar 202412.7×24.1×
28 Mar 202413.4×24.1×
5 Apr 20249.28×24.1×
12 Apr 20249.28×24.1×
19 Apr 20249.74×24.1×
26 Apr 202410.0×24.1×
3 May 202411.5×24.1×
10 May 202411.6×24.1×
17 May 202412.2×24.1×
24 May 202411.9×24.1×
31 May 202412.5×24.1×
7 Jun 202412.2×24.1×
14 Jun 202412.1×24.1×
21 Jun 202412.1×24.1×
28 Jun 202412.3×24.1×
5 Jul 202412.9×24.1×
12 Jul 202420.2×24.1×
19 Jul 202419.1×24.1×
26 Jul 202418.5×24.1×
2 Aug 202416.0×24.1×
9 Aug 202415.9×24.1×
16 Aug 202415.6×24.1×
23 Aug 202417.6×24.1×
30 Aug 202417.4×24.1×
6 Sep 202416.7×24.1×
13 Sep 202417.3×24.1×
20 Sep 202418.0×24.1×
27 Sep 202417.6×24.1×
4 Oct 202417.9×24.1×
11 Oct 202418.7×24.1×
18 Oct 202419.4×24.1×
25 Oct 202418.4×24.1×
1 Nov 202418.0×24.1×
8 Nov 202414.6×24.1×
15 Nov 202412.8×24.1×
22 Nov 202415.1×24.1×
29 Nov 202414.8×24.1×
6 Dec 202414.8×24.1×
13 Dec 202415.5×24.1×
20 Dec 202414.8×24.1×
27 Dec 202415.3×24.1×
3 Jan 202520.9×24.1×
10 Jan 202522.0×24.1×
17 Jan 202521.0×24.1×
24 Jan 202522.3×24.1×
31 Jan 202521.2×24.1×
7 Feb 202520.3×24.1×
14 Feb 202518.3×24.1×
21 Feb 202517.9×24.1×
28 Feb 202521.5×24.1×
7 Mar 202524.4×24.1×
14 Mar 202523.2×24.1×
21 Mar 202522.4×24.1×
28 Mar 202522.0×24.1×
4 Apr 202525.9×24.1×
11 Apr 202529.0×24.1×
17 Apr 202528.8×24.1×
25 Apr 202529.0×24.1×
2 May 202530.9×24.1×
9 May 202523.3×24.1×
16 May 202523.1×24.1×
23 May 202521.0×24.1×
30 May 202521.5×24.1×
6 Jun 202523.2×24.1×
13 Jun 202522.1×24.1×
20 Jun 202522.5×24.1×
27 Jun 202523.2×24.1×
3 Jul 202521.4×24.1×
11 Jul 202521.7×24.1×
18 Jul 202518.7×24.1×
25 Jul 202519.4×24.1×
1 Aug 202518.8×24.1×
8 Aug 202515.2×24.1×
15 Aug 202514.4×24.1×
22 Aug 202515.5×24.1×
29 Aug 202514.6×24.1×
5 Sep 202514.6×24.1×
12 Sep 202514.1×24.1×
19 Sep 202513.4×24.1×
26 Sep 202513.5×24.1×
3 Oct 202522.7×24.1×
10 Oct 202522.6×24.1×
17 Oct 202523.4×24.1×
24 Oct 202523.6×24.1×
31 Oct 202524.3×24.1×
7 Nov 202521.5×24.1×
14 Nov 202522.3×24.1×
21 Nov 202523.5×24.1×
28 Nov 202524.8×24.1×
5 Dec 202526.7×24.1×
12 Dec 202528.1×24.1×
19 Dec 202527.8×24.1×
26 Dec 202528.1×24.1×
2 Jan 202620.0×24.1×
9 Jan 202620.1×24.1×
16 Jan 202619.1×24.1×
23 Jan 202620.1×24.1×
30 Jan 202619.9×24.1×
6 Feb 202619.3×24.1×
13 Feb 202620.6×24.1×
20 Feb 202622.0×24.1×
27 Feb 202622.3×24.1×
6 Mar 202621.6×24.1×
13 Mar 202623.6×24.1×
20 Mar 202622.7×24.1×
27 Mar 202622.1×24.1×
2 Apr 202618.4×24.1×
10 Apr 202619.4×24.1×
17 Apr 202620.2×24.1×
24 Apr 202620.4×24.1×
1 May 202620.6×24.1×
8 May 202622.5×24.1×
15 May 202622.7×24.1×
22 May 202624.9×24.1×
29 May 202624.0×24.1×
5 Jun 202624.4×24.1×
12 Jun 202625.2×24.1×
18 Jun 202625.1×24.1×
26 Jun 202626.5×24.1×
2 Jul 202626.6×24.1×
10 Jul 202625.6×24.1×
17 Jul 202626.0×24.1×
24 Jul 202625.4×24.1×
31 Jul 202624.1×24.1×
7 Aug 202624.4×24.1×
14 Aug 202624.4×24.1×
21 Aug 202624.2×24.1×
28 Aug 202624.4×24.1×
4 Sep 202624.4×24.1×
11 Sep 202624.3×24.1×
18 Sep 202624.3×24.1×
25 Sep 202624.1×24.1×
2 Oct 202624.2×24.1×
9 Oct 202624.2×24.1×
16 Oct 202624.1×24.1×
23 Oct 202624.1×24.1×
30 Oct 202624.3×24.1×
4 Nov 202624.5×24.1×

Earnings per share, 12 months

  • Earnings per share, 12 months $4.13
Earnings per share, 12 months
WeekEarnings per share, 12 months
1 Jul 2022–
8 Jul 2022–
15 Jul 2022–
22 Jul 2022–
29 Jul 2022–
5 Aug 2022–
12 Aug 2022–
19 Aug 2022–
26 Aug 2022–
2 Sep 2022–
9 Sep 2022–
16 Sep 2022–
23 Sep 2022–
30 Sep 2022$1.48
7 Oct 2022$1.48
14 Oct 2022$1.48
21 Oct 2022$1.48
28 Oct 2022$1.48
4 Nov 2022$1.48
11 Nov 2022$1.48
18 Nov 2022$1.48
25 Nov 2022$1.48
2 Dec 2022$1.48
9 Dec 2022$1.48
16 Dec 2022$1.48
23 Dec 2022$1.48
30 Dec 2022$1.48
6 Jan 2023$1.48
13 Jan 2023$1.48
20 Jan 2023$1.48
27 Jan 2023$1.48
3 Feb 2023$1.48
10 Feb 2023$1.48
17 Feb 2023$1.48
24 Feb 2023$1.48
3 Mar 2023$1.48
10 Mar 2023$1.48
17 Mar 2023$1.48
24 Mar 2023$1.48
31 Mar 2023$0.34
6 Apr 2023$0.34
14 Apr 2023$0.34
21 Apr 2023$0.34
28 Apr 2023$0.34
5 May 2023$0.34
12 May 2023$0.34
19 May 2023$0.34
26 May 2023$0.34
2 Jun 2023$0.34
9 Jun 2023$0.34
16 Jun 2023$0.34
23 Jun 2023$0.34
30 Jun 2023$0.41
7 Jul 2023$0.41
14 Jul 2023$0.41
21 Jul 2023$0.41
28 Jul 2023$0.41
4 Aug 2023$0.41
11 Aug 2023$0.41
18 Aug 2023$0.41
25 Aug 2023$0.41
1 Sep 2023$0.41
8 Sep 2023$0.41
15 Sep 2023$0.41
22 Sep 2023$0.41
29 Sep 2023$0.41
6 Oct 2023$0.41
13 Oct 2023$0.41
20 Oct 2023$0.41
27 Oct 2023$0.41
3 Nov 2023$0.41
10 Nov 2023$0.41
17 Nov 2023$0.41
24 Nov 2023$0.41
1 Dec 2023$0.41
8 Dec 2023$0.41
15 Dec 2023$0.41
22 Dec 2023$0.41
29 Dec 2023$1.43
5 Jan 2024$1.43
12 Jan 2024$1.43
19 Jan 2024$1.43
26 Jan 2024$1.43
2 Feb 2024$1.43
9 Feb 2024$1.43
16 Feb 2024$1.43
23 Feb 2024$1.43
1 Mar 2024$1.43
8 Mar 2024$1.43
15 Mar 2024$1.43
22 Mar 2024$1.43
28 Mar 2024$4.64
5 Apr 2024$4.64
12 Apr 2024$4.64
19 Apr 2024$4.64
26 Apr 2024$4.64
3 May 2024$4.64
10 May 2024$4.64
17 May 2024$4.64
24 May 2024$4.64
31 May 2024$4.64
7 Jun 2024$4.64
14 Jun 2024$4.64
21 Jun 2024$4.64
28 Jun 2024$6.55
5 Jul 2024$6.55
12 Jul 2024$6.55
19 Jul 2024$6.55
26 Jul 2024$6.55
2 Aug 2024$6.55
9 Aug 2024$6.55
16 Aug 2024$6.55
23 Aug 2024$6.55
30 Aug 2024$6.55
6 Sep 2024$6.55
13 Sep 2024$6.55
20 Sep 2024$6.55
27 Sep 2024$6.10
4 Oct 2024$6.10
11 Oct 2024$6.10
18 Oct 2024$6.10
25 Oct 2024$6.10
1 Nov 2024$6.10
8 Nov 2024$6.10
15 Nov 2024$6.10
22 Nov 2024$6.10
29 Nov 2024$6.10
6 Dec 2024$6.10
13 Dec 2024$6.10
20 Dec 2024$6.10
27 Dec 2024$6.01
3 Jan 2025$6.01
10 Jan 2025$6.01
17 Jan 2025$6.01
24 Jan 2025$6.01
31 Jan 2025$6.01
7 Feb 2025$6.01
14 Feb 2025$6.01
21 Feb 2025$6.01
28 Feb 2025$6.01
7 Mar 2025$6.01
14 Mar 2025$6.01
21 Mar 2025$6.01
28 Mar 2025$4.36
4 Apr 2025$4.36
11 Apr 2025$4.36
17 Apr 2025$4.36
25 Apr 2025$4.36
2 May 2025$4.36
9 May 2025$4.36
16 May 2025$4.36
23 May 2025$4.36
30 May 2025$4.36
6 Jun 2025$4.36
13 Jun 2025$4.36
20 Jun 2025$4.36
27 Jun 2025$3.51
3 Jul 2025$3.51
11 Jul 2025$3.51
18 Jul 2025$3.51
25 Jul 2025$3.51
1 Aug 2025$3.51
8 Aug 2025$3.51
15 Aug 2025$3.51
22 Aug 2025$3.51
29 Aug 2025$3.51
5 Sep 2025$3.51
12 Sep 2025$3.51
19 Sep 2025$3.51
26 Sep 2025$3.75
3 Oct 2025$3.75
10 Oct 2025$3.75
17 Oct 2025$3.75
24 Oct 2025$3.75
31 Oct 2025$3.75
7 Nov 2025$3.75
14 Nov 2025$3.75
21 Nov 2025$3.75
28 Nov 2025$3.75
5 Dec 2025$3.75
12 Dec 2025$3.75
19 Dec 2025$3.75
26 Dec 2025$2.37
2 Jan 2026$2.37
9 Jan 2026$2.37
16 Jan 2026$2.37
23 Jan 2026$2.37
30 Jan 2026$2.37
6 Feb 2026$2.37
13 Feb 2026$2.37
20 Feb 2026$2.37
27 Feb 2026$2.37
6 Mar 2026$2.37
13 Mar 2026$2.37
20 Mar 2026$2.37
27 Mar 2026$3.36
2 Apr 2026$3.36
10 Apr 2026$3.36
17 Apr 2026$3.36
24 Apr 2026$3.36
1 May 2026$3.36
8 May 2026$3.36
15 May 2026$3.36
22 May 2026$3.36
29 May 2026$3.36
5 Jun 2026$3.36
12 Jun 2026$3.36
18 Jun 2026$3.36
26 Jun 2026$4.14
2 Jul 2026$4.14
10 Jul 2026$4.14
17 Jul 2026$4.14
24 Jul 2026$4.14
31 Jul 2026$4.14
7 Aug 2026$4.14
14 Aug 2026$4.14
21 Aug 2026$4.14
28 Aug 2026$4.14
4 Sep 2026$4.14
11 Sep 2026$4.14
18 Sep 2026$4.14
25 Sep 2026$4.13
2 Oct 2026$4.13
9 Oct 2026$4.13
16 Oct 2026$4.13
23 Oct 2026$4.13
30 Oct 2026$4.13
4 Nov 2026$4.13
Top: P/E each week. Below: earnings per share, trailing twelve months, a step line that moves once a quarter; 4.3 years of history; short peaks above 72× are drawn at the top edge.

PEG 1.87 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate

  • PEG 1.87×
  • PEG = 1.0 1.00×
PEG 1.87 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
QuarterPEGPEG = 1.0
Dec 20211.64×1.00×
Mar 20221.22×1.00×
Jun 20221.02×1.00×
Sep 20220.85×1.00×
Dec 20220.71×1.00×
Mar 20230.95×1.00×
Jun 20230.99×1.00×
Sep 20230.81×1.00×
Dec 20230.70×1.00×
Mar 20240.63×1.00×
Jun 20241.14×1.00×
Sep 20242.00×1.00×
Dec 20241.63×1.00×
Mar 20251.86×1.00×
Jun 20251.86×1.00×
Sep 20251.82×1.00×
Dec 20251.32×1.00×
Mar 20261.76×1.00×
Jun 20261.87×1.00×
PEG each quarter: the P/E divided by the yearly growth rate of earnings. The flat line marks 1.0. Below it the P/E is smaller than the growth rate; above it the P/E is bigger. Last 19 quarters.
24.4×P/E · higher than 54% of its last 4.3 years
1.22PEG · today, as reported

Why the multiple is where it is: over the past year earnings per share moved −21.8% while the price moved +98.0%. The price did better than earnings, which pushed the multiple up within its own range.

Where the price move came from: over 3 years the price moved +16.3% a year; about +42.5% a year came from earnings growth and about −26.2 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple.

Is the Lantheus Holdings business getting better or worse?

Lantheus Holdings, Inc.'s business is getting better. Profit growth hit its low 4 quarters ago at −44.8% and has recovered to +1.6%, with ROCE falling at 15.5%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +0.5% in FY25, profit −25.2%

  • Revenue growth 0.5%
Growth year by year: revenue +0.5% in FY25, profit −25.2%
QuarterRevenue growth
FY21–
FY22119.9%
FY2338.6%
FY2418.3%
FY250.5%

Profit growth, EPS growth

  • Profit growth −25.2%
  • EPS growth −21.8%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY21––
FY22––
FY23300%300%
FY24−4.4%−6.2%
FY25−25.2%−21.8%
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn. Turnaround-year jumps are drawn at the edge (▲).

Three growth lines over twelve quarters: revenue stabilising, profit accelerating

  • Revenue 2.3%
Three growth lines over twelve quarters: revenue stabilising, profit accelerating
QuarterRevenue
Sep 202350.4%
Dec 202338.6%
Mar 202433%
Jun 202427.8%
Sep 202424.2%
Dec 202418.3%
Mar 202512.5%
Jun 20255.7%
Sep 20251.9%
Dec 20250.5%
Mar 20260.6%
Jun 20262.3%

Profit, EPS

  • Profit 1.6%
  • EPS 10.1%
Profit, EPS
QuarterProfitEPS
Sep 2023−2.7%−3.6%
Dec 2023300%300%
Mar 2024––
Jun 2024300%300%
Sep 2024300%300%
Dec 2024−4.4%−5.9%
Mar 2025−44.8%−46.4%
Jun 2025−36.8%−38.5%
Sep 2025−60.8%−60.5%
Dec 2025−25.2%−23%
Mar 20269.7%17.9%
Jun 20261.6%10.1%
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. Extreme jumps from a tiny base are drawn at the edge (▲). A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 15.5%
ROCE: the return line, worked out each quarter
QuarterROCE
Sep 2023–
Dec 2023–
Mar 2024–
Jun 2024–
Sep 202436.4%
Dec 202427.8%
Mar 202526.6%
Jun 202524.9%
Sep 202521.7%
Dec 202517.4%
Mar 202615.2%
Jun 202615.5%
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
Steady highRevenue growth · latest +2.3%, range +0.5% to +50.4%
FlatProfit growth · latest +1.6%, range −60.8% to +1,184.0%
FlatEPS growth · latest +10.1%, range −60.5% to +1,393.2%
Turning downROCE · latest 15.5%, range 15.2% to 36.4%

Why it matters: a lasting rise from a low is what this page is built to show.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+0.5%+18.1%——
Profit−25.2%+102.6%——
EPS−21.8%+104.3%——
Stock price+98.0%+16.3%+28.5%+27.7%
+2.7%Revenue growth (Jun 2026) · latest quarter against a year ago
−4.7%Profit growth (Jun 2026) · latest quarter against a year ago
38.0%Revenue, 4 years · yearly growth over the long run

How much does Lantheus Holdings earn on its capital?

Lantheus Holdings, Inc. earned a ROE of 21% in FY25. That is up from a low of −15% in FY21. Its return on capital used (ROIC) is 13.0 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 15.2% net margin and 0.69× asset turnover (sales divided by assets).

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

Why the return is what it is (FY25): a 15.2% net margin × 0.69× asset turnover × 2.04× leverage (assets divided by equity) ≈ 21.4% on equity. The margin does most of the work; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 17.2% − 4.2% = +13.0 percentage points. The 4.2% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value.

The 17.2% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 21.6%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

FY25: ROE 21%, the climb back from FY21's −15%

  • ROE 21.4%
  • ROIC (annual) 21.6%
  • Cost of capital 4.2%
FY25: ROE 21%, the climb back from FY21's −15%
QuarterROEROIC (annual)Cost of capital
FY21−15.3%−10.8%4.2%
FY226.3%6.2%4.2%
FY2340%44%4.2%
FY2428.7%42.6%4.2%
FY2521.4%21.6%4.2%
Return on equity each year, % (line); ROIC each year, % (line). 5-year window, low years included. The flat line is the 4.2% cost of capital used on this page.

Jun 2026: ROIC 18.2% (last 12 months) against a 4.2% cost of capital

  • ROIC (12 months) 18.2%
  • ROE (12 months) 41.2%
  • Cost of capital 4.2%
Jun 2026: ROIC 18.2% (last 12 months) against a 4.2% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Sep 202317.4%75.4%4.2%
Dec 202319.3%84.4%4.2%
Mar 202462.8%54.6%4.2%
Jun 202451.8%59.5%4.2%
Sep 202445.9%25.2%4.2%
Dec 202443.9%47.5%4.2%
Mar 202542%−4.2%4.2%
Jun 202542.1%25.9%4.2%
Sep 202540.3%27%4.2%
Dec 202531.7%9.7%4.2%
Mar 202623.5%19.6%4.2%
Jun 202618.2%41.2%4.2%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 12 quarters, lined up with the yearly figure.

Does Lantheus Holdings have too much debt?

Lantheus Holdings, Inc. has total debt of $625 M against shareholder equity of $1.3 B as of Jun 2026, so its debt is 0.48× its equity. Year by year, that ratio went from 0.42 in FY21 to 0.57 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $623 M, 0.57× equity

  • Total debt $623 M
FY25: debt $623 M, 0.57× equity
QuarterTotal debt
FY21$193 M
FY22$586 M
FY23$619 M
FY24$621 M
FY25$623 M

Debt-to-equity

  • Debt-to-equity 0.57×
Debt-to-equity
QuarterDebt-to-equity
FY210.42×
FY221.31×
FY230.76×
FY240.57×
FY250.57×
Top: total debt each year, $ M. Below: debt-to-equity, ×. 5-year window.

Jun 2026: debt $625 M, debt-to-equity 0.48

  • Total debt (quarterly) $625 M
Jun 2026: debt $625 M, debt-to-equity 0.48
QuarterTotal debt (quarterly)
Sep 2023$617 M
Dec 2023$619 M
Mar 2024$619 M
Jun 2024$620 M
Sep 2024$621 M
Dec 2024$621 M
Mar 2025$614 M
Jun 2025$615 M
Sep 2025$619 M
Dec 2025$623 M
Mar 2026$626 M
Jun 2026$625 M

Debt-to-equity

  • Debt-to-equity 0.48×
Debt-to-equity
QuarterDebt-to-equity
Sep 20230.88×
Dec 20230.76×
Mar 20240.65×
Jun 20240.60×
Sep 20240.53×
Dec 20240.57×
Mar 20250.53×
Jun 20250.53×
Sep 20250.55×
Dec 20250.57×
Mar 20260.52×
Jun 20260.48×
Top: total debt each quarter, $ M. Below: debt-to-equity, ×. Last 12 quarters.

What is the Lantheus Holdings shareholding pattern?

6.2% of Lantheus Holdings, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 3.8 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

6.2%Short interest · of the tradable float
3.8Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is Lantheus Holdings from balance-sheet trouble?

For Lantheus Holdings, Inc., the Z-score is 4.48. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 4.48 is well clear of the danger zone, so the balance sheet is not the risk here.

How does Lantheus Holdings rank in its industry?

43.8 out of 100, rank 20 of 28 in Drug Manufacturers - Specialty & Generic, with 81% of the evidence available.

Lantheus Holdings, Inc. scores 43.8 out of 100 against the 28 companies it is compared with in Drug Manufacturers - Specialty & Generic, ranking 20. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 13.8 + 15.7 + 5.4 + 8.9 = 43.8. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Lantheus Holdings compared with?

Lantheus Holdings ranks 20 of 28 Drug Manufacturers - Specialty & Generic companies on the 4-Factor Sector Score, with 43.8 out of 100.

  1. 1Neurocrine Biosciences, Inc.NBIX · turning · Most evidence points up · 81% evidence66.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.1/35 · Revenue 34.4% · Profit 100% · Operating margin change 1 points · 83% evidenceCapital efficiency 18.2/25 · ROCE 19.3% · Operating margin 22.2% · 76% evidenceValuation 13.8/20 · P/E 24× · PEG 0.71 · 65% evidenceRelative strength 8.2/20 · Lead over its industry -5.3% · Lead over S&P 500 6.1% · 1 year 9% · 100% evidence · 0 of 12 weeks aheadExact sum: 26.1 + 18.2 + 13.8 + 8.2 = 66.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  2. 2Indivior Pharmaceuticals, Inc.INDV · quiet · Evidence leans up · 71% evidence63.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 27.8/35 · Revenue 13.5% · Profit 100% · Operating margin change 23.4 points · 83% evidenceCapital efficiency 20.8/25 · ROCE 152.3% · Operating margin 46.9% · 76% evidenceValuation 10.3/20 · P/E 14.1× · PEG — · 15% evidenceRelative strength 4.3/20 · Lead over its industry -13.9% · Lead over S&P 500 -3.7% · 1 year 15.8% · 100% evidence · 0 of 12 weeks aheadExact sum: 27.8 + 20.8 + 10.3 + 4.3 = 63.2 · What this means: Earnings are strong; relative strength in its sector is -13.9% and the one-year return is 15.8%.
  3. 3Kiniksa Pharmaceuticals International, plcKNSA · leader · Evidence leans up · 71% evidence62.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.1/35 · Revenue 58.7% · Profit 100% · Operating margin change -1.7 points · 83% evidenceCapital efficiency 12.2/25 · ROCE 13.8% · Operating margin 11.2% · 76% evidenceValuation 9.0/20 · P/E 61× · PEG — · 15% evidenceRelative strength 16.8/20 · Lead over its industry 43.2% · Lead over S&P 500 59% · 1 year 150.5% · 100% evidence · 12 of 12 weeks aheadExact sum: 24.1 + 12.2 + 9 + 16.8 = 62.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4Bausch Health Companies Inc.BHC · leader · Evidence leans up · 71% evidence60.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.9/35 · Revenue 10.1% · Profit -1220.4% · Operating margin change 9.1 points · 83% evidenceCapital efficiency 12.8/25 · ROCE 13.5% · Operating margin 27.2% · 76% evidenceValuation 10.9/20 · P/E -1.7× · PEG — · 15% evidenceRelative strength 18.5/20 · Lead over its industry 17.1% · Lead over S&P 500 30.9% · 1 year 25.4% · 100% evidence · 12 of 12 weeks aheadExact sum: 17.9 + 12.8 + 10.9 + 18.5 = 60.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  5. 5Xeris Biopharma Holdings, Inc.XERS · leader · Evidence leans up · 64% evidence60.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.1/35 · Revenue 36.2% · Profit — · Operating margin change -0.7 points · 62% evidenceCapital efficiency 11.8/25 · ROCE 16.5% · Operating margin 5.6% · 76% evidenceValuation 8.7/20 · P/E 83.3× · PEG — · 15% evidenceRelative strength 18.4/20 · Lead over its industry 18.3% · Lead over S&P 500 31.8% · 1 year 40.8% · 100% evidence · 12 of 12 weeks aheadExact sum: 21.1 + 11.8 + 8.7 + 18.4 = 60 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Phibro Animal Health CorporationPAHC · breaking out · Evidence leans up · 81% evidence58.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.4/35 · Revenue 17.2% · Profit 100% · Operating margin change 0.3 points · 83% evidenceCapital efficiency 15.3/25 · ROCE 16.4% · Operating margin 10.6% · 76% evidenceValuation 11.8/20 · P/E 12.8× · PEG 1.44 · 65% evidenceRelative strength 7.1/20 · Lead over its industry -19.8% · Lead over S&P 500 -10.4% · 1 year -9.9% · 100% evidence · 11 of 12 weeks aheadExact sum: 24.4 + 15.3 + 11.8 + 7.1 = 58.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7Amneal Pharmaceuticals, Inc.AMRX · leader · Evidence leans up · 71% evidence58.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.4/35 · Revenue 9.3% · Profit 100% · Operating margin change 2.8 points · 83% evidenceCapital efficiency 15.1/25 · ROCE 17.1% · Operating margin 18.3% · 76% evidenceValuation 9.3/20 · P/E 35.1× · PEG — · 15% evidenceRelative strength 12.8/20 · Lead over its industry 11.3% · Lead over S&P 500 23.9% · 1 year 75.5% · 100% evidence · 10 of 12 weeks aheadExact sum: 21.4 + 15.1 + 9.3 + 12.8 = 58.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  8. 8BioCryst Pharmaceuticals, Inc.BCRX · quiet · Evidence leans up · 64% evidence58.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.6/35 · Revenue 68.5% · Profit — · Operating margin change 26.9 points · 62% evidenceCapital efficiency 18.1/25 · ROCE 112% · Operating margin 45.1% · 76% evidenceValuation 11.0/20 · P/E -6.6× · PEG — · 15% evidenceRelative strength 3.6/20 · Lead over its industry -18% · Lead over S&P 500 -8.4% · 1 year 16.2% · 100% evidence · 3 of 12 weeks aheadExact sum: 25.6 + 18.1 + 11 + 3.6 = 58.3 · What this means: Earnings are strong; relative strength in its sector is -18% and the one-year return is 16.2%.
  9. 9Liquidia CorporationLQDA · quiet · Evidence leans up · 64% evidence55.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.0/35 · Revenue 100% · Profit — · Operating margin change 474.2 points · 62% evidenceCapital efficiency 17.9/25 · ROCE 50.7% · Operating margin 49.8% · 76% evidenceValuation 9.2/20 · P/E 51.2× · PEG — · 15% evidenceRelative strength 2.7/20 · Lead over its industry -19.6% · Lead over S&P 500 -10.2% · 1 year 81.6% · 100% evidence · 3 of 12 weeks aheadExact sum: 26 + 17.9 + 9.2 + 2.7 = 55.8 · What this means: Earnings are strong; relative strength in its sector is -19.6% and the one-year return is 81.6%.
  10. 10United Therapeutics CorporationUTHR · turning · Evidence leans up · 81% evidence55.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 14.5/35 · Revenue 2.5% · Profit 5.6% · Operating margin change -6.2 points · 83% evidenceCapital efficiency 20.3/25 · ROCE 21.2% · Operating margin 42.2% · 76% evidenceValuation 9.2/20 · P/E 17.5× · PEG 1.92 · 65% evidenceRelative strength 11.4/20 · Lead over its industry -2.5% · Lead over S&P 500 8.9% · 1 year 35.5% · 100% evidence · 3 of 12 weeks aheadExact sum: 14.5 + 20.3 + 9.2 + 11.4 = 55.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  11. 11Viatris Inc.VTRS · breaking out · Evidence leans up · 64% evidence52.4out of 100GrowthCapitalValuationRelative
  12. 12Trulieve Cannabis Corp.TRLV · breaking out · Evidence leans up · 64% evidence50.8out of 100GrowthCapitalValuationRelative
  13. 13Pacira BioSciences, Inc.PCRX · breaking out · Evidence leans up · 64% evidence50.3out of 100GrowthCapitalValuationRelative
  14. 14ANI Pharmaceuticals, Inc.ANIP · basing · Evidence leans down · 64% evidence48.3out of 100GrowthCapitalValuationRelative
  15. 15Zoetis Inc.ZTS · turning · Evidence leans down · 81% evidence47.1out of 100GrowthCapitalValuationRelative
  16. 16Teva Pharmaceutical Industries LimitedTEVA · leader · Evidence leans down · 64% evidence46.9out of 100GrowthCapitalValuationRelative
  17. 17Haleon plcHLN · basing · Too little evidence to rank firmly · 56% evidence46.2out of 100GrowthCapitalValuationRelative
  18. 18Perrigo Company plcPRGO · breaking out · Evidence leans down · 64% evidence45.1out of 100GrowthCapitalValuationRelative
  19. 19Elanco Animal Health IncorporatedELAN · turning · Evidence leans down · 71% evidence44.9out of 100GrowthCapitalValuationRelative
  20. 20Lantheus Holdings, Inc. this pageLNTH · turning · Evidence leans down · 81% evidence43.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 13.8/35 · Revenue 2.3% · Profit 1.5% · Operating margin change 2.5 points · 83% evidenceCapital efficiency 15.7/25 · ROCE 14.6% · Operating margin 25.8% · 76% evidenceValuation 5.4/20 · P/E 26.2× · PEG 2.59 · 65% evidenceRelative strength 8.9/20 · Lead over its industry -0.9% · Lead over S&P 500 10.4% · 1 year 98% · 100% evidence · 0 of 12 weeks aheadExact sum: 13.8 + 15.7 + 5.4 + 8.9 = 43.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  21. 21Alkermes plcALKS · quiet · Evidence leans down · 81% evidence43.6out of 100GrowthCapitalValuationRelative
  22. 22HUTCHMED (China) LimitedHCM · breaking out · Too little evidence to rank firmly · 51% evidence40.8out of 100GrowthCapitalValuationRelative
  23. 23Prestige Consumer Healthcare Inc.PBH · basing · Evidence leans down · 71% evidence37.8out of 100GrowthCapitalValuationRelative
  24. 24AlvotechALVO · breaking out · Most evidence points down · 71% evidence33.7out of 100GrowthCapitalValuationRelative
  25. 25Hims & Hers Health, Inc.HIMS · quiet · Most evidence points down · 71% evidence27.4out of 100GrowthCapitalValuationRelative
  26. 26Supernus Pharmaceuticals, Inc.SUPN · quiet · Most evidence points down · 71% evidence26.6out of 100GrowthCapitalValuationRelative
  27. 27Amylyx Pharmaceuticals, Inc.AMLX · leader · Too little evidence to rank firmly · 40% evidence47.7out of 100GrowthCapitalValuationRelative
  28. 28Regencell Bioscience Holdings LimitedRGC · losing its lead · Too little evidence to rank firmly · 47% evidence30.6out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Drug Manufacturers - Specialty & Generic, all 28 compared on one page.

Which companies are close to Lantheus Holdings in size?

Lantheus Holdings is the 13th largest of 51 Drug Manufacturers - Specialty & Generic companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Alkermes plc, Kiniksa Pharmaceuticals International, plc and Amneal Pharmaceuticals, Inc. Just below it: Hims & Hers Health, Inc., Liquidia Corporation and Amylyx Pharmaceuticals, Inc.

Drug Manufacturers - Specialty & Generic companies close in size

  1. Alkermes plc $7.7 billion
  2. Kiniksa Pharmaceuticals International, plc $7.6 billion
  3. Amneal Pharmaceuticals, Inc. $6.9 billion
  4. Lantheus Holdings, Inc. $6.6 billion
  5. Hims & Hers Health, Inc. $6.2 billion
  6. Liquidia Corporation $4.2 billion
  7. Amylyx Pharmaceuticals, Inc. $3.7 billion

All 51 Drug Manufacturers - Specialty & Generic companies, largest first

Companies close in size in other industries

  1. United Bankshares, Inc. $6.6 billion · Banks - Regional
  2. Liberty Broadband Corporation $6.6 billion · Telecom Services
  3. Lantheus Holdings, Inc. $6.6 billion
  4. RingCentral, Inc. $6.6 billion · Software - Application
  5. Hess Midstream LP $6.6 billion · Oil & Gas Midstream

What else do people ask about Lantheus Holdings?

What were Lantheus Holdings's latest quarterly results?

Lantheus Holdings, Inc. reported revenue of $388 M and net profit of $75.0 M for the Jun 2026 quarter. Revenue rose 2.7% and profit fell 4.7% compared with a year earlier. Earnings per share were $1.11.

The operating margin was 25.8%, 2.5 percentage points higher than a year earlier (as of 4 November 2026).

What is Lantheus Holdings's market cap?

Lantheus Holdings, Inc.'s market capitalisation is $6.6 B at a stock price of $101.14. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is Lantheus Holdings performing?

Lantheus Holdings, Inc.'s share price has been rising for 18 weeks. In its latest quarter, revenue rose 2.7% and profit fell 4.7% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 1 week running (as of 4 November 2026).

Will Lantheus Holdings's stock price go up?

This page does not forecast Lantheus Holdings, Inc.'s stock price. What it shows instead: the stock price is $101.14, and it has been rising for 18 weeks. Its P/E of 24.4× is higher than 54% of its own last 4 years (as of 4 November 2026).

Where is Lantheus Holdings in its business cycle?

Lantheus Holdings, Inc.'s FY25 operating margin was 20.3%, against a 5-year range of −15.7% to 29.1%: the middle of its own range, neither a peak nor a low. The latest quarter was 25.8%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the Lantheus Holdings story?

The main question: the share price moved +98.0% in a year while yearly earnings per share moved −21.8%. The difference came from the market paying a higher multiple.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is Lantheus Holdings a stock worth studying right now?

What the numbers show: Lantheus Holdings, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.